Trial results for a study investigating adherence to referral eye care visits for conditions including Diabetic Retinopathy were posted on ClinicalTrials.gov on 2025-07-25. The study enrolled 900 participants.
Background
Glaucoma, diabetic retinopathy, and other eye conditions like cataracts and refractive errors represent significant public health challenges, particularly in vulnerable populations. Glaucoma, for instance, is a leading cause of blindness, especially in older adults and African Americans, often diagnosed late. Early detection and consistent management are crucial to prevent vision loss across these conditions. However, adherence to follow-up eye care referrals can be a significant barrier to effective disease management. Developing novel healthcare models that improve the ability to detect and manage these diseases, particularly in community-based settings, is essential to prevent further vision loss and improve accessibility to care.
Trial design
This completed study, designated as Phase NA, enrolled 900 participants to investigate adherence to referral eye care visits. The conditions studied included Glaucoma, Diabetic Retinopathy, Refractive Errors, and Cataract, alongside aspects of Behavior, Health. The trial aimed to improve the quality and accessibility of eye care detection and management. Participants were assigned to either a group receiving a financial incentive or a group receiving no financial incentive to encourage adherence to their referral appointments.
Key results
The trial measured the adherence of participants to their referral appointments:
- In the group that received No Financial Incentive, the number of participants who adhered to their referral appointment was 80.
- In the group that received a Financial Incentive, the number of participants who adhered to their referral appointment was 92.
What this means
The results suggest that providing financial incentives may improve adherence to referral eye care appointments for individuals with conditions such as diabetic retinopathy, glaucoma, and others. This finding indicates that such incentives could be a practical strategy to encourage patients to follow through with recommended specialist visits. Improved adherence to referrals could lead to earlier diagnosis, more timely intervention, and better long-term outcomes for patients at risk of vision loss from various eye diseases.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT04328207, titled "Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits", were posted on 2025-07-25 on clinicaltrials.gov.